Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease

医学 非酒精性脂肪肝 二甲双胍 2型糖尿病 内科学 糖尿病 人口 脂肪肝 疾病 胃肠病学 胰岛素 内分泌学 环境卫生
作者
Heejoon Jang,Yeonjin Kim,Dong Hyeon Lee,Sae Kyung Joo,Bo Kyung Koo,Soo Lim,Woojoo Lee,Won Kim
出处
期刊:JAMA Internal Medicine [American Medical Association]
卷期号:184 (4): 375-375 被引量:84
标识
DOI:10.1001/jamainternmed.2023.8029
摘要

Importance: Several oral antidiabetic drug (OAD) classes can potentially improve patient outcomes in nonalcoholic fatty liver disease (NAFLD) to varying degrees, but clinical data on which class is favored are lacking. Objective: To investigate which OAD is associated with the best patient outcomes in NAFLD and type 2 diabetes (T2D). Design, Setting, and Participants: This retrospective nonrandomized interventional cohort study used the National Health Information Database, which provided population-level data for Korea. This study involved patients with T2D and concomitant NAFLD. Exposures: Receiving either sodium-glucose cotransporter 2 (SGLT2) inhibitors, thiazolidinediones, dipeptidyl peptidase-4 (DPP-4) inhibitors, or sulfonylureas, each combined with metformin for 80% or more of 90 consecutive days. Main Outcomes and Measures: The main outcomes were NAFLD regression assessed by the fatty liver index and composite liver-related outcome (defined as liver-related hospitalization, liver-related mortality, liver transplant, and hepatocellular carcinoma) using the Fine-Gray model regarding competing risks. Results: In total, 80 178 patients (mean [SD] age, 58.5 [11.9] years; 43 007 [53.6%] male) were followed up for 219 941 person-years, with 4102 patients experiencing NAFLD regression. When compared with sulfonylureas, SGLT2 inhibitors (adjusted subdistribution hazard ratio [ASHR], 1.99 [95% CI, 1.75-2.27]), thiazolidinediones (ASHR, 1.70 [95% CI, 1.41-2.05]), and DPP-4 inhibitors (ASHR, 1.45 [95% CI, 1.31-1.59]) were associated with NAFLD regression. SGLT2 inhibitors were associated with a higher likelihood of NAFLD regression when compared with thiazolidinediones (ASHR, 1.40 [95% CI, 1.12-1.75]) and DPP-4 inhibitors (ASHR, 1.45 [95% CI, 1.30-1.62]). Only SGLT2 inhibitors (ASHR, 0.37 [95% CI, 0.17-0.82]), not thiazolidinediones or DPP-4 inhibitors, were significantly associated with lower incidence rates of adverse liver-related outcomes when compared with sulfonylureas. Conclusions and Relevance: The results of this cohort study suggest that physicians may lean towards prescribing SGLT2 inhibitors as the preferred OAD for individuals with NAFLD and T2D, considering their potential benefits in NAFLD regression and lower incidences of adverse liver-related outcomes. This observational study should prompt future research to determine whether prescribing practices might merit reexamination.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
曲奇完成签到 ,获得积分10
刚刚
自由的舞蹈完成签到,获得积分10
1秒前
过时的傲玉完成签到 ,获得积分10
1秒前
优秀的雪碧完成签到,获得积分10
1秒前
rechristal完成签到,获得积分10
1秒前
灯灯完成签到,获得积分10
1秒前
yellow完成签到,获得积分10
1秒前
123完成签到,获得积分10
1秒前
小菜完成签到,获得积分10
1秒前
羽林完成签到 ,获得积分10
2秒前
12完成签到,获得积分10
2秒前
2秒前
mu完成签到,获得积分10
2秒前
2秒前
qiuling完成签到,获得积分10
3秒前
3秒前
榴榴完成签到 ,获得积分10
3秒前
1255475177完成签到 ,获得积分10
3秒前
jin_strive完成签到,获得积分10
4秒前
大方菲音完成签到,获得积分10
4秒前
Eric完成签到 ,获得积分10
4秒前
今天值班的不是我完成签到,获得积分10
4秒前
爱听歌时光完成签到,获得积分10
4秒前
没有脑袋完成签到,获得积分10
4秒前
Ds完成签到,获得积分10
4秒前
john完成签到,获得积分10
5秒前
5秒前
5秒前
HowesFeng完成签到,获得积分10
5秒前
沐沐小米完成签到,获得积分10
6秒前
cindy完成签到 ,获得积分10
6秒前
Lchemistry完成签到,获得积分10
7秒前
7秒前
余倾发布了新的文献求助10
7秒前
SHUNLI0205发布了新的文献求助10
7秒前
JamesPei的应助被呼呼呼呼胡采纳,获得10
7秒前
Kiry完成签到 ,获得积分10
8秒前
cnas完成签到,获得积分10
8秒前
jokerli完成签到,获得积分10
9秒前
sfliufighting完成签到,获得积分10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8152197
求助须知:如何正确求助?哪些是违规求助? 9548983
关于积分的说明 21689256
捐赠科研通 7740443
什么是DOI,文献DOI怎么找? 3425145
关于科研通互助平台的介绍 2550358
邀请新用户注册赠送积分活动 2468604